Peter A. Thompson's Trading History
| SIONSionna Therapeutics, Inc. | Jul 09, 2026 | Director | Uninformative Sell | 3.85M | $9.56M | |
| CRVSCorvus Pharmaceuticals | Jan 30, 2026 | Director, Ten Percent Owner | Uninformative Buy | 1.12M | $88.46M | |
| EWTXEdgewise Therapeutics | Apr 04, 2025 | Director, Ten Percent Owner | Informative Buy | 10.00M | $17.26M | |
| SPRYARS Pharmaceuticals | Aug 28, 2024 | Director | Informative Sell | 1.09M | $28.02M | |
| ALPNAlpine Immune Sciences | May 20, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| JANXJanux Therapeutics Inc | Dec 30, 2021 | Director | Informative Sell | 820.12K | $4.04M | |
| DBTXDecibel Therapeutics | Feb 19, 2021 | ― | Uninformative Buy | ― | $4.34M | |
| PMVPPMV Pharmaceuticals | Sep 29, 2020 | Director, Ten Percent Owner | Uninformative Buy | ― | $149.39K | |
| ~~THORSynthorx | Jan 24, 2020 | ― | Uninformative Sell | 361.51M | $0.00 | |
| PRVLPrevail Therapeutics | Jun 26, 2019 | ― | Uninformative Buy | ― | $317.92M | |
| ~THORThoratec Corp | Dec 13, 2018 | ― | Uninformative Buy | ― | $337.59M | |
| ADAPYAdaptimmune Therapeutics | Jun 06, 2018 | Director | Informative Sell | 253.63K | $112.73K | |
| MRTXMirati Therapeutics | ― | ― | ― | $0.00 | ||
| ANTHAnthera Pharmaceuticals | ― | Director | ― | ― |
You May Also Like
Peter A. Thompson insider profile FAQ
What is the percentage of profitable transactions made by Peter A. Thompson?
The percentage of profitable transactions made by Peter A. Thompson is 66%.
What is the average return per transaction made by Peter A. Thompson?
The average return per transaction made by Peter A. Thompson is 33.10%.
What stocks does Peter A. Thompson hold?
Peter A. Thompson holds: SION, ANTH, ~THOR, ADAPY, ALPN, CRVS, ~~THOR, PRVL, PMVP, SPRY, DBTX, EWTX, JANX, MRTX stocks.
What was Peter A. Thompson’s latest transaction?
Peter A. Thompson’s latest transaction was an Uninformative Sell of $3.85M.
What was Peter A. Thompson's most profitable transaction?
Peter A. Thompson’s most profitable transaction was an Informative Buy of EWTX stock on April 4, 2025. The return on the trade was 189.50%.
What is Peter A. Thompson's role in Sionna Therapeutics, Inc.?
Peter A. Thompson's role in Sionna Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.